In the second study, In this study effects of sorafenib in HCC. Sorafenib is FDA the treatment of HCC the treatment of HCC, which typically arises in cirrhosis, which can withstand conventional chemotherapy. The researchers previously demonstrated that vitamin K of of HCC growth alone. In this study, they found that the combination inhibits the growth of HCC, cell death and decreases the expression of ERK. – ‘Many patients need to discontinue treatment with sorafenib because of the debilitating side effects,’Carr said. ‘If we could reduce the dose , more patients would be able treatment.’.

Both as painful sores on the soles of of the feet of patients prevent the patients from walking can, Dr. Profound fatigue and weight loss said, is also observed in at least 30 % of patients. – In the pancreatic cancer study, Dr. Carr and his colleagues tested each K vitamin in combination with sorafenib in pancreatic cell lines. Any combination of cell growth, cell death and decreased the expression of ERK. They found that when combining reduced vitamin K, and sorafenib, the sorafenib dose.Replication Medical a developer of of proprietary, hydrogel based products for spinal column and other surgical applications, has reported that it is to assign a qualifying session Therapeutic Discovery Project grant from the U.S. Government totaling $ 244,479 to 2009 GelStix Replication Medical research is based issues. To product is GelStix in chronic of low back pain fast nearly 10-15 percent of adults and has with state, degenerative disc degenerative disc disease famous. Source: Replication Medical.

Medical Inc. Of Medical Receives contribution of virtually $ 250.00 on his heels Success clinical findings with its innovative GelStix treatment.